We are live on
!
Find out more
SGH
Sivik Global Healthcare Portfolio holdings
AUM
$132M
1-Year Est. Return
24.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$274M
AUM Growth
+$28.9M
(+12%)
Cap. Flow
+$18.1M
Cap. Flow
% of AUM
6.61%
Top 10 Holdings %
Top 10 Hldgs %
33.26%
Holding
58
New
20
Increased
13
Reduced
10
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$9.27M |
| 2 |
Intuitive Surgical
ISRG
|
+$7.55M |
| 3 |
Cencora
COR
|
+$6.22M |
| 4 |
Waters Corp
WAT
|
+$5.87M |
| 5 |
Fresenius Medical Care
FMS
|
+$5.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$9.66M |
| 2 |
Elevance Health
ELV
|
+$6.42M |
| 3 |
Eli Lilly
LLY
|
+$5.91M |
| 4 |
Cardinal Health
CAH
|
+$5.36M |
| 5 |
Guardant Health
GH
|
+$5.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.59% |
Similar funds
AFP
TCPW
GCM
PF
PCGDR
ACM
A
SPWM
Sivik Global Healthcare's Q1 2021 Portfolio in Review
As of Q1 2021, Sivik Global Healthcare held 58 positions worth $274M, up 12% from $245M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Sivik Global Healthcare deployed $18.1M of net new capital in Q1 2021, opening 20 new positions and adding to 13 existing holdings. Its largest new stake was Agilent Technologies: 75,000 shares worth $9.54M.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.
On the sell side, the largest reduction was Guardant Health, an estimated $5.29M trimmed.
- Sivik Global Healthcare's largest Q1 2021 buy was Agilent Technologies: 75,000 shares worth $9.54M.
- Sivik Global Healthcare added most to Encompass Health in Q1 2021, an estimated $3.69M increase.
- Sivik Global Healthcare's biggest Q1 2021 reduction was Guardant Health, cutting an estimated $5.29M.
- Sivik Global Healthcare fully exited Regeneron Pharmaceuticals in Q1 2021, selling an estimated $9.66M.
- Sivik Global Healthcare's ten largest holdings make up 33% of its $274M portfolio in Q1 2021.
- Sivik Global Healthcare opened 20 new positions and closed 11 in Q1 2021.
- Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $274M.
Based on Sivik Global Healthcare's 13F filing for Q1 2021, filed 12 May 2021.